Innovative Health Wins $147 Million Antitrust Verdict Against Johnson & Johnson’s Biosense Webster

Medical Device Reprocessing Company Innovative HealthSuing Johnson & Johnson SubsidiaryBiosense WebsterJohnson & Johnson MedTech Monopoly Case Supported by California Jury, Ruled in Favor$147 million in compensation. The core issue in this case is that the defendant ceased providing free technical support to medical institutions using third-party reprocessed electrophysiology catheters approximately ten years ago (Carto 3), services are only available to customers who purchase its original factory catheters.

Plaintiff and Defendant Dispute

• Plaintiff's Position

Innovative Health Specializes in the Reprocessing of Single-Use Medical Devices in the Cardiology Field, Gaining FDA Approval for the Reuse of "Discarded" Catheters. It Alleges That Biosense WebsterTechnical Support Bundling Strategy, forcing hospitals to abandon the lower-cost reprocessed catheters, constitutes exclusionary conduct violating federal and state antitrust laws.

• Defendant's Defense

Johnson & Johnson Medical Technology Department responded by expressing "disappointment with the verdict," emphasizing that its policies are "aimed at ensuring patient safety and product performance," and stated that it will evaluate legal options such as an appeal. During the previous trial, the defendant had argued that the clinical support system and proprietary equipment...Technical Indivisibility, analogous to the logic defense of "buying shoes requires laces".

"For a long time, Johnson & Johnson has been using bundling agreements and other strategies to interfere with fair competition from lower-cost, FDA-regulated reprocessed 'single-use' devices (SUDs). We hope this jury verdict will draw widespread attention: hospitals want to reduce costs and greenhouse gas emissions by using more reprocessed SUDs without fear of retaliation from original equipment manufacturers (OEMs)."

---Daniel J. Vukelich  Chairman and CEO of the Association of Medical Device Reprocessors

In the United States, there is a large business where some medical device companies recycle disposable medical devices used by hospitals and, through processes such as cleaning, decontaminate them.Disposable medical devices are cleaned, sterilized, and then resold to hospitals.

These reprocessing companies that reprocess single-use medical devices can significantly impact the profits of companies producing these devices. In response, major manufacturers like Johnson & Johnson and Medtronic have started implementing various measures to prevent their single-use medical devices from being reused (for example, embedding chips within the devices to limit usage by number of times or duration). These measures have proven quite effective but, unfortunately, severely affect the interests of the reprocessing companies.

Therefore, many reprocessing companies have sued the original equipment manufacturers for monopoly.Innovative Health's lawsuit against Johnson & Johnson is the best example. Although the reprocessing company won this victory, the original equipment manufacturer will surely retaliate in the future.The reprocessing company and the original manufacturer are completely at odds with each other.The existence of reprocessing companies will seriously affect the interests of the original manufacturer.